Lpl Financial LLC Heron Therapeutics, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 65,657 shares of HRTX stock, worth $73,535. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,657

Previous 65,332 0.5%

Holding current value

$73,535

Previous $228,000 42.98%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$1.73 - $3.67 $562 - $1,192	325 Added 0.5%	65,657 $130,000
Q2 2024 Aug 07, 2024	BUY	$2.32 - $3.86 $32,343 - $53,812	13,941 Added 27.13%	65,332 $228,000
Q1 2024 May 10, 2024	BUY	$1.71 - $3.06 $39,394 - $70,496	23,038 Added 81.25%	51,391 $142,000
Q4 2023 Feb 14, 2024	SELL	$0.54 - $1.82 $2,344 - $7,902	-4,342 Reduced 13.28%	28,353 $48,000
Q3 2023 Nov 13, 2023	SELL	$0.97 - $1.8 $805 - $1,494	-830 Reduced 2.48%	32,695 $33,000
Q2 2023 Jul 31, 2023	BUY	$1.11 - $2.88 $22,838 - $59,256	20,575 Added 158.88%	33,525 $38,000
Q1 2023 May 10, 2023	BUY	$1.51 - $3.25 $1,510 - $3,250	1,000 Added 8.37%	12,950 $19,000
Q4 2022 Feb 07, 2023	SELL	$2.25 - $4.67 $4,500 - $9,340	-2,000 Reduced 14.34%	11,950 $29,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $2,926 - $5,907	-1,100 Reduced 7.31%	13,950 $59,000
Q2 2022 Aug 12, 2022	SELL	$2.3 - $6.29 $3,334 - $9,120	-1,450 Reduced 8.79%	15,050 $42,000
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $1,157 - $2,485	250 Added 1.54%	16,500 $94,000
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $10,913 - $16,468	1,307 Added 8.75%	16,250 $148,000
Q3 2021 Nov 15, 2021	SELL	$10.13 - $15.0 $55,937 - $82,830	-5,522 Reduced 26.98%	14,943 $160,000
Q2 2021 Aug 13, 2021	BUY	$13.27 - $18.48 $69,866 - $97,297	5,265 Added 34.64%	20,465 $318,000
Q1 2021 May 14, 2021	BUY	$14.49 - $20.72 $43,325 - $61,952	2,990 Added 24.49%	15,200 $246,000
Q4 2020 Feb 12, 2021	SELL	$14.61 - $22.14 $139,861 - $211,946	-9,573 Reduced 43.95%	12,210 $258,000
Q3 2020 Nov 09, 2020	BUY	$13.67 - $17.77 $42,718 - $55,531	3,125 Added 16.75%	21,783 $323,000
Q2 2020 Aug 13, 2020	BUY	$10.89 - $21.47 $203,185 - $400,587	18,658 New	18,658 $274,000
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $184,320 - $250,982	-6,144 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $162,201 - $258,048	6,144 New	6,144 $239,000

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Heron Therapeutics, Inc. Transaction History